Free Newsletter
Scientists find new white blood cell for immunology
Two white blood cells known as Th1 and Th2 have long been recognized for their powerful role in directing immune cells to fight infections and some cancers. Now, though, scientists have identified a third white blood cell that works in tandem with Th1 and Th2, and the discovery is promising to shake up research projects for rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.
- here's the article from AL.com
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: